» Articles » PMID: 19207714

Lifestyle Factors and Colorectal Cancer Risk (1): Systematic Review and Meta-analysis of Associations with Body Mass Index

Overview
Journal Colorectal Dis
Specialty Gastroenterology
Date 2009 Feb 12
PMID 19207714
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Excess body weight, defined by body mass index (BMI), may increase the risk of colorectal cancer. As a prerequisite to the determination of lifestyle attributable risks, we undertook a systematic review and meta-analysis of prospective observational studies to quantify colorectal cancer risk associated with increased BMI and explore for differences by gender, sub-site and study characteristics.

Method: We searched MEDLINE and EMBASE (to December 2007), and other sources, selecting reports based on strict inclusion criteria. Random-effects meta-analyses and meta-regressions of study-specific incremental estimates were performed to determine the risk ratio (RR) and 95% confidence intervals (CIs) associated with a 5 kg/m(2) increase in BMI.

Results: We analysed 29 datasets from 28 articles, including 67,361 incident cases. Higher BMI was associated with colon (RR 1.24, 95% CIs: 1.20-1.28) and rectal (1.09, 1.05-1.14) cancers in men, and with colon cancer (1.09, 1.04-1.12) in women. Associations were stronger in men than in women for colon (P < 0.001) and rectal (P = 0.005) cancers. Associations were generally consistent across geographic populations. Study characteristics and adjustments accounted for only moderate variations of associations.

Conclusion: Increasing BMI is associated with a modest increased risk of developing colon and rectal cancers, but this modest risk may translate to large attributable proportions in high-prevalence obese populations. Inter-gender differences point to potentially important mechanistic differences, which merit further research.

Citing Articles

Central obesity may account for most of the colorectal cancer risk linked to obesity: evidence from the UK Biobank prospective cohort.

Safizadeh F, Mandic M, Schottker B, Hoffmeister M, Brenner H Int J Obes (Lond). 2024; .

PMID: 39562688 DOI: 10.1038/s41366-024-01680-7.


Examination of Sarcopenia with Obesity as a Prognostic Factor in Patients with Colorectal Cancer Using the Psoas Muscle Mass Index.

Haruna K, Minami S, Miyoshi N, Fujino S, Mizumoto R, Toyoda Y Cancers (Basel). 2024; 16(19).

PMID: 39410049 PMC: 11482590. DOI: 10.3390/cancers16193429.


Association between Surrogate Markers of Insulin Resistance and the Incidence of Colorectal Cancer in Korea: A Nationwide Population-Based Study.

Son M, Moon S, Koh M, Kang Y, Lee J J Clin Med. 2024; 13(6).

PMID: 38541854 PMC: 10971512. DOI: 10.3390/jcm13061628.


The risk of colorectal cancer according to obesity status at four-year intervals: a nationwide population-based cohort study.

Seo J, Jin E, Chung G, Kim Y, Bae J, Yim J Sci Rep. 2023; 13(1):8928.

PMID: 37264099 PMC: 10235025. DOI: 10.1038/s41598-023-36111-6.


Combined Effect of Healthy Lifestyle Factors and Risks of Colorectal Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality: Systematic Review and Meta-Analysis.

Yu J, Feng Q, Kim J, Zhu Y Front Oncol. 2022; 12:827019.

PMID: 35936678 PMC: 9353059. DOI: 10.3389/fonc.2022.827019.